Ad
related to: dapoxetine priligy
Search results
Results From The WOW.Com Content Network
Dapoxetine, sold under the brand name Priligy among others, is a selective serotonin reuptake inhibitor (SSRI) used for the treatment of premature ejaculation (PE) in men ages 18 to 64 years old. [ 3 ] [ 4 ] [ 5 ] Dapoxetine works by inhibiting the serotonin transporter , increasing serotonin's action at the postsynaptic cleft, and as a ...
Reports of PSSD have occurred with almost every SSRI (dapoxetine is an exception). [64] In 2019, the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA) recommended that packaging leaflets of selected SSRIs and SNRIs should be amended to include information regarding a possible risk of persistent sexual ...
Less often, SRIs are also used to treat a variety of other medical conditions including neuropathic pain and fibromyalgia (e.g., duloxetine, milnacipran), and premature ejaculation (e.g., dapoxetine) as well as for dieting (e.g., sibutramine).
Selective serotonin reuptake inhibitors, or serotonin-specific re-uptake inhibitor (SSRIs), are a class of chemical compounds that have application as antidepressants and in the treatment of depression and other psychiatric disorders.
Dapoxetine in particular takes advantage of the side effect of delayed orgasm and is approved specifically as a medication for the treatment of premature ejaculation rather than as an antidepressant. The side effects on sexual functioning can impact mental health and quality of life. [ 36 ]
Dapoxetine is intended for "as needed" dosing and should not reach steady state at all, thus discontinuation syndromes are expected to be minimal. —Preceding unsigned comment added by 64.118.220.25 ( talk ) 16:01, 21 February 2008 (UTC) ->Why would the DEA be interested in a medication designed to prevent PE?
This article was reviewed by Kelly Brown MD, MBA. If you’ve just started taking Cialis, don’t be alarmed if you feel a little off. Like other medications for the treatment of (ED), Cialis ...
This is a list of investigational antidepressants, or drugs that are currently under development for clinical use in the treatment of depression but are not yet approved. . Specific indications include major depressive disorder, treatment-resistant depression, dysthymia, bipolar depression, and postpartum depression, among oth